Average Co-Inventor Count = 5.52
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novo Nordisk A/s (10 from 1,778 patents)
2. Novo Nordisk Healthcare Ag (6 from 88 patents)
3. Danmarks Tekniske Universitet (2 from 229 patents)
4. University of Copenhagen (2 from 79 patents)
5. Novo Nordick A/s (1 from 6 patents)
6. Noro Nordisk A/s (1 from 5 patents)
20 patents:
1. 12227528 - Glucose-sensitive albumin-binding derivatives
2. 11767332 - Glucose-sensitive albumin-binding derivatives
3. 11186595 - Glucose-sensitive albumin-binding derivatives
4. 10889845 - Production of N-glycoproteins for enzyme assisted glycomodification
5. 10858671 - N-glycosylation
6. 10179905 - Factor VII conjugates
7. 9695226 - Growth hormones with prolonged in-vivo efficacy
8. 9370583 - Coagulation factor VII polypeptides
9. 9234192 - Conjugated proteins
10. 9018166 - Conjugated FVIII variants
11. 8865868 - Conjugated proteins with prolonged in vivo efficacy
12. 8779109 - Growth hormones with prolonged in-vivo efficacy
13. 8053410 - Pegylated factor VII glycoforms
14. 6953812 - Glucagon antagonists/inverse agonists
15. 6927214 - Non-peptide GLP-1 agonists